Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kyverna Therapeutics, Inc. | 0 | 4,523,924 | +4,523,924 | 0 | 112,374 | 62.43% | +112,374 |
| Centessa Pharmaceuticals plc | 3,931,818 | 3,931,818 | 0 | 31,297 | 44,430 | 24.68% | +13,132 |
| Allogene Therapeutics, Inc. | 1,798,163 | 1,798,163 | 0 | 5,772 | 8,038 | 4.47% | +2,266 |
| Kronos Bio, Inc. | 2,765,314 | 2,765,314 | 0 | 3,457 | 3,595 | 2.00% | +138 |
| Ikena Oncology, Inc. | 225,192 | 0 | -225,192 | 444 | 0 | — | -444 |
| Kinnate Biopharma, Inc. | 2,207,772 | 0 | -2,207,772 | 5,232 | 0 | — | -5,232 |
| LianBio | 2,282,084 | 0 | -2,282,084 | 10,201 | 0 | — | -10,201 |
| Dyne Therapeutics, Inc.(DYN) | 2,074,787 | 407,499 | -1,667,288 | 27,595 | 11,569 | 6.43% | -16,026 |